The Efficacy and Safety of Roxadustat for Anemia in Patients With Chronic Kidney Disease: A Meta-Analysis

Background: Chronic kidney disease (CKD) is a global public health problem, and anemia is a common complication in CKD patients. Roxadustat (FG-4592) is an oral hypoxia-inducible factor (HIF) stabilizer. Roxadustat has been shown in studies to keep up with and increase hemoglobin better than placebo...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lijun, Yin, Heng, Yang, Liling, Zhang, Fenglian, Wang, Song, Liao, Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086555/
https://www.ncbi.nlm.nih.gov/pubmed/35559232
http://dx.doi.org/10.3389/fphar.2022.779694

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086555/
https://www.ncbi.nlm.nih.gov/pubmed/35559232
http://dx.doi.org/10.3389/fphar.2022.779694

Ejemplares similares